Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Jean-François Cavalier
Senior researcher (CRCN)
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
The development of new and effective antimicrobial compounds is urgent due to the emergence of resistant bacteria. Natural plant flavonoids are known to be effective molecules, but their activity and selectivity have to be increased. Based on previous aurone potency, we designed new aurone derivatives bearing acetamido and amino groups at the position 5 of the A ring and managing various monosubstitutions at the B ring. A series of 31 new aurone derivatives were first evaluated for their antimicrobial activity with five derivatives being the most active (compounds 10, 12, 15, 16, and 20). The evaluation of their cytotoxicity on human cells and of their therapeutic index (TI) showed that compounds 10 and 20 had the highest TI. Finally, screening against a large panel of pathogens confirmed that compounds 10 and 20 possess large spectrum antimicrobial activity, including on bioweapon BSL3 strains, with MIC values as low as 0.78 µM. These results demonstrate that 5-acetamidoaurones are far more active and safer compared with 5-aminoaurones, and that benzyloxy and isopropyl substitutions at the B ring are the most promising strategy in the exploration of new antimicrobial aurones.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (17)
Magali Casanova
Aix-Marseille University
Maxime Robin
Aix-Marseille University
Jean Michel Brunel
Aix-Marseille University
Victoria Magrioti
Associate Professor
National and Kapodistrian University of Athens
Paweł Bakun
Doctor, Head of the Pharmaceutical Nanotechnology Laboratory at PUMS
Poznan University of Medical Sciences
Mickael Lafond
-
Marek Murias
professor
Poznan University of Medical Sciences
Céline Crauste
Université de Montpellier
Jean Michel Bolla
Head of Laboratory
INSERM
Vadim Shlyonsky
Université libre de Bruxelles (ULB)
Stephane Canaan
CNRS Délégation Provence et Corse
Vincent LE MOIGNE
Université de Versailles Saint-Quentin-en-Yvelines
Marc Maresca
Maitre de conférence
Aix-Marseille University
Jordan Lehoux
University of Otago
Priscille Brodin
Research Director
INSERM
Laurent Kremer
Head of team "Mycobacterial Pathogenesis and Novel Therapeutic Targets
University of Montpellier
Werner Kaminsky
X-Ray Crystallographer
University of Washington
Make your next move.
Prepare your application
Review drafts before you send them.